glp-1 compounding crackdown news october 2025 The growing availability of compounded weight-loss drugs has prompted warnings from doctors and the U.S. Food and Drug Administration. https://www.wavy.com/news/national/compounded-glp-1-drugs-creating-concern-among-doctors-and-fda/?utm_medium GLP-1 weight loss drugs are

Exploring the Role of GLP-1 Receptor Agonists in Alzheimers Disease: A Review of Preclinical and Clinical Evidence

Research indicates that 60-70% of TRT patients achieve stable estradiol control within 12 weeks of starting anastrozole therapy when properly dosed and monitored

About 10.3% of patients on the 36 mg dose stopped the drug because of side effects, compared with 2.6% on placebo

Helps heal the tissues: Could accelerate the healing of the lining of the gut, skin, muscles, tendons, ligaments, and joints

Metformin, the second most commonly prescribed medication in the US in 2023, was first synthesized by scientists in 1922 and has been widely used to treat type 2 diabetes since the mid-20th century